FIELD: pharmacology.
SUBSTANCE: refers to application of compounds of common formula 1 
for production of medicinal agent for inhibition of cdc25-phosphatases and/or CD45- phosphatase, medicinal agent for inhibition of cdc25-phosphatases or CD45- phosphatase, pharmaceutical formulations for inhibition of cdc25-phosphatases or CD45-phosphatase; invention also refers to compounds of formula 1 and provides high-degree inhibition of cdc25-phosphatases and/or CD45- phosphatase.
EFFECT: high degree of inhibition.
22 cl, 1 dwg, 3 tbl, 131 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PHOSPHATASE Cdc25 INHIBITORS | 2005 |
|
RU2395510C2 |
| DERIVATIVES OF FIVE-MEMBER HETEROCYCLES, METHOD OF PRODUCTION AND USE THEREOF AS MEDICINAL AGENTS | 2000 |
|
RU2380362C2 |
| FIVE-MEROUS HETEROCYCLE DERIVATIVES, METHOD FOR PREPARING AND USING THEM AS THERAPEUTIC AGENTS | 2009 |
|
RU2530882C2 |
| DERIVATIVES OF FIVE-MEMBERED HETEROCYCLES, METHOD FOR THEIR PREPARING AND THEIR USING AS MEDICINES | 2000 |
|
RU2271355C2 |
| PHOSPHATASE INHIBITORS cdc25 | 2001 |
|
RU2285521C2 |
| METHODS AND COMPOSITIONS FOR IMPROVING COGNITIVE FUNCTIONS | 2012 |
|
RU2665021C2 |
| NOVEL DERIVATIVES OF ARYLIMIDAZOLE, THEIR PREPARATIONS AND THEIR THERAPEUTIC USES | 2003 |
|
RU2323216C2 |
| SUBSTITUTED DIKETOPIPERAZINES AS OXYTOCIN ANTAGONISTS | 2002 |
|
RU2303032C2 |
| SUBSTITUTED METHYLPHENYL KETONES SUITABLE FOR USE AS PDE4 INHIBITORS | 2007 |
|
RU2493149C2 |
| DERIVATIVES OF FIVE-MEMBERED HETEROCYCLES, THEIR PREPARING AND USING AS MEDICINAL AGENTS | 2002 |
|
RU2288224C2 |
